An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

A new nasal spray that uses a form of ketamine to treat stubborn depression will be added to the PBS, making treatment ...

May marks Mental Health Awareness Month, a crucial time to elevate the conversation around mental wellness, reduce stigma, and advocate for access to care. With an estimated 59.3 million U.S.

Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Johnson & Johnson ...

A groundbreaking nasal spray using a form of ketamine to treat stubborn depression is set to become more accessible and affordable for thousands of Australians. The spray, known as Spravato, will be ...

Unlike older medications that target serotonin – a “feel-good” chemical in the brain – the ketamine-based nasal spray works ...

A drug derived from ketamine will be added to the PBS, helping tens of thousands of Australians struggling with depression to ...